{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Rad Chat","title":"Bonus Episode: Dr. John Christodouleas - MR Linac Research","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/cf6b7fa1\"></iframe>","width":"100%","height":180,"duration":2607,"description":"Naman Julka-Anderson and Jo McNamara catch up with Dr. John Christodouleas about his career, medical affairs and MR Linac based research.\n \nTo use this podcast as CPD, look at these reflection points: \n1) reflect on your motivations for working in healthcare.\n2) consider the differences in private and public healthcare.\n3) consider ways to improve access to radiotherapy.\n\nComplete this form for your accredited digital badge: https://bit.ly/3GbtR1X.\n\nLinks from podcast:\nMR-Linac Consortium Website: https://mrlconsortium.org\nEvolution of the MOMENTUM Study for Evidence-Based Implementation of MR-Guided Radiotherapy Using the 1.5 Tesla MR-Linac: https://www.redjournal.org/article/S0360-3016(23)06346-0/fulltext\nOutcomes of Tolerability, Acute Toxicity and Quality of Life from MR-Guided Radiation Therapy (1.5T MR-Linac) for Liver Metastases in the MOMENTUM Study: https://www.redjournal.org/article/S0360-3016(23)05415-9/fulltext\nPatient-Reported Outcomes of Rectal Cancer Patients Treated on a 1.5T MR-Linac within the MOMENTUM Study: https://www.redjournal.org/article/S0360-3016(23)05720-6/fulltext\nOptimising the MR-Linac as a standard treatment modality: https://onlinelibrary.wiley.com/doi/10.1002/jmrs.712\nInterim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging–Guided Adaptive Prostate Radiation Therapy: https://www.redjournal.org/article/S0360-3016(23)07949-X/fulltext\nDevelopment of prostate bed delineation consensus guidelines for MRI-guided radiotherapy and assessment of its impact on interobserver variability: https://www.redjournal.org/article/S0360-3016(23)07848-3/fulltext\nGating and intrafraction drift correction on a 1.5 T MR-Linac: Clinical dosimetric benefits for upper abdominal tumors: Gating and intrafraction drift correction on a 1.5 T MR-Linac: Clinical dosimetric benefits for upper abdominal tumors - Radiotherapy and Oncology(thegreenjournal.com)\n\nPlease like and subscribe to Rad Chat on your podcast...","thumbnail_url":"https://img.transistorcdn.com/0wFiffqRab_C_nPB5bCBJUg_mULsM2eF_DxRLoq0kVA/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xZDE3/OGQ3YjY4OTE4Yjkz/ZmQzNTJhNDlkYmQz/OTY3ZC5KUEc.webp","thumbnail_width":300,"thumbnail_height":300}